NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

特殊學名藥的全球市場:產業趨勢,市場佔有率、規模、成長率、機會及預測(2021年∼2026年)

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版商 IMARC Services Private Limited 商品編碼 999876
出版日期 內容資訊 英文 144 Pages
商品交期: 2-3個工作天內
價格
特殊學名藥的全球市場:產業趨勢,市場佔有率、規模、成長率、機會及預測(2021年∼2026年) Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
出版日期: 2021年05月20日內容資訊: 英文 144 Pages
簡介

全球特殊學名藥的市場規模,2020年達到了573億美元。特殊學名藥,是專利到期的特殊醫藥品的非專利版。這些藥使用於癌症,自體免疫疾病,癲癇,HIV,肝炎,多發性硬化症,類風濕性關節炎等慢性疾病或併發症的治療。特殊非專利,因為不需高價的開發費與行銷費用,比品牌醫藥品成本效益高。

高齡化人口增加,多數品牌特殊醫藥品的專利到期,癌症、多發性硬化症、HIV等的各種致死性疾病的盛行率增加,來自醫療保健供應商的成本控制對策,新興市場的成長等,成為市場成長的促進因素。全球特殊學名藥市場,預計今後5年顯示強力的成長。

本報告提供全球特殊學名藥市場的相關調查,提供產業趨勢,市場預測,各給藥途徑、適應症、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍和調查方法

第3章 摘要整理

第4章 全球特殊學名藥市場:簡介

第5章 特殊學名藥的有利點

第6章 全球特殊學名藥市場

  • 市場概要
  • 市場成果
  • COVID-19的影響
  • 各給藥途徑的市場區隔
  • 各適應症的市場區隔
  • 各流通管道的市場區隔
  • 各地區的市場區隔
  • SWOT分析
    • 概要
    • 優勢
    • 弱點
    • 市場機會
    • 威脅
  • 價值鏈分析
  • 波特五力分析
  • 主要的市場成長要素與成功因素

第7章 各給藥途徑的市場區隔

  • 注射劑
  • 口服
  • 其他

第8章 各適應症的市場區隔

  • 腫瘤學
  • 自體免疫疾病
  • 感染疾病
  • 其他

第9章 各流通管道的市場區隔

  • 零售藥局
  • 專門藥局
  • 醫院藥局

第10章 各地區的市場區隔

  • 北美
    • 市場概要
    • 市場成果
    • 各國市場區隔
    • 美國
    • 加拿大
  • 歐洲
    • 市場概要
    • 市場成果
    • 各國市場區隔
    • 義大利
    • 德國
    • 法國
    • 英國
    • 西班牙
  • 亞太地區
    • 市場概要
    • 市場成果
    • 各國市場區隔
    • 日本
    • 中國
    • 印度
    • 韓國
  • 南美
    • 市場概要
    • 市場成果
    • 各國市場區隔
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 市場概要
    • 市場成果

第11章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
目錄
Product Code: SR1020C78_Report

The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit strong growth during the next five years. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Scope:

  • Historical, Current and Future Market Trends

Market Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:

  • The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What has been the impact of COVID-19 on the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
    • 10.1.4 United States
      • 10.1.4.1 Market Trends
      • 10.1.4.2 Market Forecast
    • 10.1.5 Canada
      • 10.1.5.1 Market Trends
      • 10.1.5.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Germany
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 France
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 United Kingdom
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
    • 10.2.8 Spain
      • 10.2.8.1 Market Trends
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
    • 10.3.4 Japan
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 China
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 India
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 South Korea
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
    • 10.4.4 Brazil
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Mexico
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 9: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
  • Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
  • Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
  • Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
  • Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
  • Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
  • Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
  • Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
  • Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players